Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) (C-Term), (AA 100-170) antibody

Details for Product No. ABIN350689
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms
P27, ISG12, FAM14D, ISG12A, KIP1, MEN4, CDKN4, MEN1B, P27KIP1, AA408329, AI843786, Kip1, p27, p27Kip1, 1500011J20Rik, 2610202L11Rik, Bridge-1, Cdki1b, cdkn1b, sb:cb611, wu:fb63g10, wu:fb64g10, wu:fe18 ... show more
P27, ISG12, FAM14D, ISG12A, KIP1, MEN4, CDKN4, MEN1B, P27KIP1, AA408329, AI843786, Kip1, p27, p27Kip1, 1500011J20Rik, 2610202L11Rik, Bridge-1, Cdki1b, cdkn1b, sb:cb611, wu:fb63g10, wu:fb64g10, wu:fe18e03, CDKN1B show less
Epitope
C-Term, AA 100-170
(51), (44), (27), (27), (21), (20), (12), (9), (4), (3), (3), (3), (3), (3), (3), (3), (3), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity
Rat (Rattus)
(346), (173), (146), (81), (61), (54), (36), (13), (6), (3), (3), (1), (1), (1), (1)
Host
Rabbit
(309), (64), (14), (1), (1)
Clonality
Polyclonal
Conjugate
Un-conjugated
(13), (8), (6), (6), (6), (6), (6), (6), (6), (6), (6), (2), (2)
Application
Immunohistochemistry (IHC), Western Blotting (WB)
(261), (129), (91), (60), (60), (55), (29), (21), (12), (10), (6), (5), (1)
Pubmed 5 references available
Catalog no. ABIN350689
Quantity 100 µL
Price
454.67 $   Plus shipping costs $45.00
Options
Shipping to United States (Change)
Availability Will be delivered in 7 to 8 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen A synthetic peptide from c-terminal region (~aa 100-170) of human p27 Kip1 (KIP1, p27Kip1) conjugated to an immunogenic carrier protein was used as the antigen.
Specificity Specific for TAS2R16.
Purification Purified human T-Cells
whole serum
Alternative Name p27 Kip1
Background Function: Important regulator of cell cycle progrssion. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Positive regulator of cyclin D-dependent kinases such as CDK4. Regulated by phosphorylation and degradation events. Decreased levels of p27Kip1, mainly due to proteosomal degradation, are found in various epithelial tumors originating from lung, breast, colon, ovary, esophagus, thyroid and prostate.
Subcellular location: Nucleus. Cytoplasm. Note: Nuclear and cytoplasmic in quiescent cells.
Tissue specificity: Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney. Also known as: Cyclin-dependent kinase inhibitor 1B, Cyclin-dependent kinase inhibitor p27, CDKN1B, KIP1, p27Kip1, p27 Kip 1.
UniProt Q9JKU0
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Not tested in other applications.
Restrictions For Research Use only
Format Liquid
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage -20 °C
Storage Comment Maintain the reconstituted antibodies frozen at -20 °C for long term storage and refrigerated at 2-8 °C for a shorter term.
Expiry Date 12 months
General Pietenpol, Bohlander, Sato et al.: "Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias." in: Cancer research, Vol. 55, Issue 6, pp. 1206-10, 1995 (PubMed).

Polyak, Lee, Erdjument-Bromage et al.: "Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals." in: Cell, Vol. 78, Issue 1, pp. 59-66, 1994 (PubMed).

Ishida, Kitagawa, Hatakeyama et al.: "Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability." in: The Journal of biological chemistry, Vol. 275, Issue 33, pp. 25146-54, 2000 (PubMed).

Viglietto, Motti, Bruni et al.: "Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer." in: Nature medicine, Vol. 8, Issue 10, pp. 1136-44, 2002 (PubMed).

Grimmler, Wang, Mund et al.: "Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases." in: Cell, Vol. 128, Issue 2, pp. 269-80, 2007 (PubMed).

Hosts (309), (64), (14), (1), (1)
Reactivities (346), (173), (146), (81), (61), (54), (36), (13), (6), (3), (3), (1), (1), (1), (1)
Applications (261), (129), (91), (60), (60), (55), (29), (21), (12), (10), (6), (5), (1)
Conjugates (13), (8), (6), (6), (6), (6), (6), (6), (6), (6), (6), (2), (2)
Epitopes (51), (44), (27), (27), (21), (20), (12), (9), (4), (3), (3), (3), (3), (3), (3), (3), (3), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top